{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:57:41Z","timestamp":1762163861504,"version":"build-2065373602"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,3]]},"DOI":"10.7759\/cureus.95985","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:49:36Z","timestamp":1762163376000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Pitfall of Lytic Bone Lesions: A Case of Chromophobe Renal Cell Carcinoma Coexisting With Multiple Myeloma"],"prefix":"10.7759","author":[{"given":"Aaeshah M","family":"Almutairi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Abusedera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan M","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1590\/0100-3984.2013.1927","article-title":"Renal cell carcinoma: histological classification and correlation with imaging findings","volume":"48","author":"Muglia VF","year":"2015","unstructured":"Muglia VF, Prando A. Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras. 2015, 48:166-74. 10.1590\/0100-3984.2013.1927","journal-title":"Radiol Bras"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-28-134","article-title":"Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease","volume":"28","author":"Stec R","year":"2009","unstructured":"Stec R, Grala B, M\u0105czewski M, Bodnar L, Szczylik C. Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease. J Exp Clin Cancer Res. 2009, 28:134. 10.1186\/1756-9966-28-134","journal-title":"J Exp Clin Cancer Res"},{"key":"ref3","unstructured":"Medical News Today. Chromophobe renal cell carcinoma. signs, staging, and outlook. (2022). Accessed: May 12, 2025: https:\/\/www.medicalnewstoday.com\/articles\/chromophobe-renal-cell-carcinoma."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2024.109608","article-title":"A case-report of chromophobe renal cell carcinoma with renal subcapsular hematoma","volume":"118","author":"Yin Y","year":"2024","unstructured":"Yin Y, Tang S. A case-report of chromophobe renal cell carcinoma with renal subcapsular hematoma. Int J Surg Case Rep. 2024, 118:109608. 10.1016\/j.ijscr.2024.109608","journal-title":"Int J Surg Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-022-03688-x","article-title":"Bone metastatic carcinoma coexisting with plasma cell myeloma: a case\u00a0report","volume":"16","author":"Aloui M","year":"2022","unstructured":"Aloui M, Ben Rejeb S, Boudokhan M, Dhaoui A, Ben Romdhane M, Belakhal S. Bone metastatic carcinoma coexisting with plasma cell myeloma: a case\u00a0report. J Med Case Rep. 2022, 16:477. 10.1186\/s13256-022-03688-x","journal-title":"J Med Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133337","article-title":"Presenting symptoms in newly diagnosed myeloma, relation to organ damage, and implications for symptom-directed screening: a secondary analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial","volume":"15","author":"Bowcock S","year":"2023","unstructured":"Bowcock S, Atkin C, Iqbal G, et al.. Presenting symptoms in newly diagnosed myeloma, relation to organ damage, and implications for symptom-directed screening: a secondary analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial. Cancers (Basel). 2023, 15:3337. 10.3390\/cancers15133337","journal-title":"Cancers (Basel)"},{"key":"ref7","article-title":"A patient with multiple myeloma and renal cell carcinoma","volume":"10","author":"Shahi F","year":"2016","unstructured":"Shahi F, Ghalamkari M, Mirzania M, Khatuni M. A patient with multiple myeloma and renal cell carcinoma. Int J Hematol Oncol Stem Cell Res. 2016, 10:56-60.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"ref8","article-title":"Coexistence of multiple myeloma and clear cell renal cell carcinoma: a case report and review of literature","volume":"8","author":"Xu G","year":"2015","unstructured":"Xu G, Yang M, Huang J, Jin J. Coexistence of multiple myeloma and clear cell renal cell carcinoma: a case report and review of literature. Int J Clin Exp Pathol. 2015, 8:7627-30.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7796.134292","article-title":"Renal cell carcinoma and plasma cell myeloma: unique association and clinical implications","volume":"6","author":"Padhi S","year":"2014","unstructured":"Padhi S, Sahoo PK, Banerjee D, Ghosh RN. Renal cell carcinoma and plasma cell myeloma: unique association and clinical implications. Urol Ann. 2014, 6:252-6. 10.4103\/0974-7796.134292","journal-title":"Urol Ann"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1206368","article-title":"Multiple myeloma following bone metastasis of renal cell carcinoma: a case report","volume":"14","author":"Yu H","year":"2023","unstructured":"Yu H, Zhang S, Feng X, Gao F. Multiple myeloma following bone metastasis of renal cell carcinoma: a case report. Front Endocrinol (Lausanne). 2023, 14:1206368. 10.3389\/fendo.2023.1206368","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.20517\/2394-4722.2021.88","article-title":"Management of bone metastases in renal cell carcinoma: bone-targeted treatments, systemic therapies, and radiotherapy","volume":"7","author":"Mansinho A","year":"2021","unstructured":"Mansinho A, Nejo P, Leit\u00e3o T, Casimiro S, Costa L. Management of bone metastases in renal cell carcinoma: bone-targeted treatments, systemic therapies, and radiotherapy. J Cancer Metastasis Treat. 2021, 7:44. 10.20517\/2394-4722.2021.88","journal-title":"J Cancer Metastasis Treat"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/104546","article-title":"Diagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvement","volume":"2013","author":"Tosi P","year":"2013","unstructured":"Tosi P. Diagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvement. Scientifica (Cairo). 2013, 2013:104546. 10.1155\/2013\/104546","journal-title":"Scientifica (Cairo)"},{"key":"ref13","unstructured":"International Myeloma Working Group (IMWG) criteria for the diagnosis of multiple myeloma. (2015). Accessed. May 12, 2025: https:\/\/www.myeloma.org\/international-myeloma-working-group-imwg-criteria-diagnosis-multiple-myeloma."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-30003-1_17","article-title":"Imaging of bone metastases","author":"Sik Kang H","year":"2006","unstructured":"Sik Kang H, Ah Choi J. Imaging of bone metastases. Imaging of Kidney Cancer. Medical Radiology. Guermazi A (ed): Springer, Berlin, Heidelberg; 2006. 309-20. 10.1007\/3-540-30003-1_17"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09892.x","article-title":"The association between renal cell carcinoma and multiple myeloma: insights from population-based data","volume":"108","author":"Ojha RP","year":"2011","unstructured":"Ojha RP, Evans EL, Felini MJ, Singh KP, Thertulien R. The association between renal cell carcinoma and multiple myeloma: insights from population-based data. BJU Int. 2011, 108:825-30. 10.1111\/j.1464-410X.2010.09892.x","journal-title":"BJU Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020216","article-title":"Signaling pathway mediating myeloma cell growth and survival","volume":"13","author":"Hideshima T","year":"2021","unstructured":"Hideshima T, Anderson KC. Signaling pathway mediating myeloma cell growth and survival. Cancers (Basel). 2021, 13:216. 10.3390\/cancers13020216","journal-title":"Cancers (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.9972","article-title":"PI3K\/AKT\/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (review)","volume":"21","author":"Miricescu D","year":"2021","unstructured":"Miricescu D, Balan DG, Tulin A, et al.. PI3K\/AKT\/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (review). Exp Ther Med. 2021, 21:540. 10.3892\/etm.2021.9972","journal-title":"Exp Ther Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106273242613","article-title":"Interleukin-6 produced by renal-cell carcinoma cells and progression of multiple myeloma","volume":"324","author":"Sakai A","year":"1991","unstructured":"Sakai A, Kawano M, Kuramoto A. Interleukin-6 produced by renal-cell carcinoma cells and progression of multiple myeloma. N Engl J Med. 1991, 324:1893-4. 10.1056\/NEJM199106273242613","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail D","year":"2013","unstructured":"Quail D, Joyce J. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013, 19:1423-37. 10.1038\/nm.3394","journal-title":"Nat Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/381472-diagnostic-pitfall-of-lytic-bone-lesions-a-case-of-chromophobe-renal-cell-carcinoma-coexisting-with-multiple-myeloma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:49:37Z","timestamp":1762163377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/381472-diagnostic-pitfall-of-lytic-bone-lesions-a-case-of-chromophobe-renal-cell-carcinoma-coexisting-with-multiple-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.95985","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,11,3]]}}}